Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rangering i aksjer #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aksjekurs
$0.2219522
Sist synkronisert: 2025-09-11
Markedsverdi
$1.10B
Endring (1 dag)
0.04%
Endring (1 år)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS per September 2024 TTM: $-0.02
Ifølge de siste økonomiske rapportene og aksjekursen til Hubei Biocause Pharmaceutical Co., Ltd. er selskapets nåværende EPS (TTM) $-0.02. Ved slutten av 2022 hadde selskapet en EPS på $0.01, en nedgang sammenlignet med EPS-en i 2021 som var $0.03.
EPS-historikk for Hubei Biocause Pharmaceutical Co., Ltd. fra 2000 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.02 -21.50%
2023 $-0.02 -226.90%
2022 $0.01 -48.76%
2021 $0.03 -19.60%
2020 $0.04 -58.44%
2019 $0.08 115.52%
2018 $0.04 -14.75%
2017 $0.05 -27.29%
2016 $0.06 128.88%
2015 $0.03 185.57%
2014 $0.01 -178.23%
2013 $-0.01 -985.71%
2012 0.00 -111.76%
2011 $-0.01 -471.88%
2010 0.00 -40.74%
2009 $0.01 -292.86%
2008 0.00 -122.58%
2007 $0.01 113.79%
2006 $0.01 625.00%
2005 0.00 33.33%
2004 0.00 -111.54%
2003 $-0.01 -966.67%
2002 0.00 -80.65%
2001 0.00 0.00%
2000 0.00 0.00%
EPS for lignende selskaper eller konkurrenter